KLRS- Kalaris Therapeutics, Inc.
Kalaris Therapeutics, Inc. (KLRS) has 2 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. KLRS is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.22M | $9.32M | - | |
| CFO | 235.0K | $984.7K | - |
Activity
Buys and sells only
Transactions
10 filings · page 3
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 22, 2024 | Miller Edward82 | General Counsel | Sell | 1,401 | $0.77 | $1,082.80 | -0.3% | -47.6% | -75.5% | |
| Oct 22, 2024 | Sinha Vikas84 | See Remarks | Sell | 3,428 | $0.77 | $2,649.33 | -0.1% | -47.6% | -75.5% | |
| Oct 21, 2024 | Brainard Diana85 | Chief Executive Officer | Sell | 9,752 | $0.78 | $7,596.81 | -1.3% | -47.4% | -73.5% | |
| Oct 3, 2024 | Sinha Vikas84 | See Remarks | Sell | 940 | $0.81 | $765.91 | - | -45.0% | -64.7% | |
| Oct 3, 2024 | Miller Edward82 | General Counsel | Sell | 377 | $0.81 | $307.18 | -0.2% | -45.0% | -64.7% | |
| Oct 3, 2024 | Brainard Diana85 | Chief Executive Officer | Sell | 1,493 | $0.81 | $1,216.50 | -0.2% | -45.0% | -64.7% | |
| Oct 3, 2024 | Hagen Brett R84 | Chief Accounting Officer | Sell | 301 | $0.81 | $245.25 | -0.4% | -45.0% | -64.7% | |
| Aug 20, 2024 | Brainard Diana85 | Chief Executive Officer | Sell | 5,390 | $0.74 | $3,995.61 | -0.7% | -23.3% | -85.2% | |
| Aug 19, 2024 | Miller Edward82 | General Counsel | Sell | 422 | $0.76 | $320.51 | -0.2% | -24.6% | -85.4% | |
| Aug 19, 2024 | Hagen Brett R84 | Chief Accounting Officer | Sell | 544 | $0.76 | $413.17 | -0.8% | -24.6% | -85.4% |